IL1A and cryopyrin-associated periodic syndrome: Systemic AA amyloidosis, a life-threatening complication of SAIDs that mainly presents with renal involvement, was reported to occur in approximately 25% of CAPS patients prior to targetted treatment with IL1 blockade (52).